Delivery systems and molecular targets of mechanism-based therapies for GBM-Reference-Cited by-同舟云学术

Delivery systems and molecular targets of mechanism-based therapies for GBM

Published:2004-07 Issue:4 Volume:4 Page:649-663
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Phuphanich Surasak,Brat Daniel J,Olson Jeffrey J

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Neurology (clinical),General Neuroscience

Link

http://www.tandfonline.com/doi/pdf/10.1586/14737175.4.4.649

Reference87 articles.

1. Malignant glioma: Who benefits from adjuvant chemotherapy?

2. Bailey P, Cushing HA. Classification of Tumors of the Glioma Group. Lippincott, PA, USA (1926).

3. Burger P, Scheitauer BW. TUMOIN of the Central Nervous System. Forces Institute of Pathology, Washington DC, USA (1994).

4. Kleihues P, Cavenee W World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of the Nervous System. International Agency for Research on Cancer. IARC Press, Lyon, France (2000).

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor‐targeted nanotherapeutics: overcoming treatment barriers for glioblastoma;WIREs Nanomedicine and Nanobiotechnology;2016-11-04

2. Crossing the barrier: treatment of brain tumors using nanochain particles;WIREs Nanomedicine and Nanobiotechnology;2016-01-09

3. Leptomeningeal and intramedullary metastases of glioblastoma multiforme in a patient reoperated during adjuvant radiochemotherapy;World Journal of Surgical Oncology;2013-03-05

4. Cytogenetic Characterizations of Central Nervous System Tumors: The First Comprehensive Report from a Single Institution in Korea;Journal of Korean Medical Science;2009

5. The Protein Phosphatase Activity of PTEN Regulates Src Family Kinases and Controls Glioma Migration;Cancer Research;2008-03-13